Ticker
$LAB
1 catalyst touching LAB in the last 60 days, newest first, each with the price move that followed.
- 72
Standard BioTools to sell Microfluidics business to ARCHIMED
Standard BioTools entered a definitive agreement to sell its Microfluidics business to ARCHIMED, expected to close in ~30 days. The filing does not disclose the sale price or relative revenue contribution of the unit, limiting confidence in quantifying the transaction's materiality to the overall business.
LAB ·SEC 8-K · 5 Oct 2026, 20:16 UTC
Information only. AURA does not give buy or sell recommendations.